Study and results
Thirty-six men with depression stabilized on fluoxetine entered a four-week randomized, blinded trial of saffron or placebo. Thirty completed the study. [1]
Erectile-function, intercourse-satisfaction and total questionnaire scores favored saffron. Orgasmic function, overall satisfaction and sexual-desire scores did not significantly differ from placebo. [1]
Interpretation and limitations
The regimen was one tested intervention, not a dose-optimization experiment. The small selected sample and short follow-up limit broader inference. Funding and conflicts were not established from the abstract, and similar reported side-effect frequency does not establish safety for every medicine combination. [1]
A hypothetical distinction
Imagine a questionnaire total improves because two domains change. That cannot be translated into a claim that every aspect of sexual function improves.
| Detail | Interpretation |
|---|---|
| Erectile function | One domain |
| Sexual desire | Separate null result |
| Optimal dose | Not compared |
Sources for this article
- Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.